0000920465-19-000011.txt : 20190109 0000920465-19-000011.hdr.sgml : 20190109 20190109212945 ACCESSION NUMBER: 0000920465-19-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190107 FILED AS OF DATE: 20190109 DATE AS OF CHANGE: 20190109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TIDMARSH GEORGE F CENTRAL INDEX KEY: 0001287235 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 19519168 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 wf-form4_154708736639403.xml FORM 4 X0306 4 2019-01-07 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001287235 TIDMARSH GEORGE F C/O LA JOLLA PHARMACEUTICAL COMPANY, 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 1 1 0 0 President, CEO & Secretary Common Stock 2019-01-07 4 P 0 82 5.85 A 1281408 D Common Stock 2019-01-07 4 P 0 287 5.85 A 1281695 D Common Stock 2019-01-07 4 P 0 98 5.85 A 1281793 D Common Stock 2019-01-07 4 P 0 397 5.85 A 1282190 D Common Stock 2019-01-07 4 P 0 700 5.85 A 1282890 D Common Stock 2019-01-07 4 P 0 436 5.85 A 1283326 D Common Stock 22000 I By children /s/ Ryan Murr, as attorney-in-fact for George F. Tidmarsh 2019-01-09